SEC Form D · filed May 18, 2023
NovaBay Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Audrey M. Kunin · KANSAS CITY, MOExec · DirectorSwan E. Sit · EMERYVILLE, CADirectorMijia (Bob) E. Wu · EMERYVILLE, CADirectorJustin M. Hall · EMERYVILLE, CAExec · DirectorYenyou (Jeff) E. Zheng · EMERYVILLE, CADirectorJulie Garlikov · EMERYVILLE, CADirectorTommy Law · EMERYVILLE, CAExecJeffrey M. Kunin · KANSAS CITY, MOExecPaul E. Freiman · EMERYVILLE, CADirectorYongxiang (Sean) Zheng · EMERYVILLE, CADirectorBhavika Vyas · New York, NYDirectorCato Partners GP, LLC · New York, NYDirectorJorge E. Bartolome · Chapel Hill, NCDirectorJill M. Smith · Huxley, IAExec · DirectorSamuel Schreiber · Chilmark, MADirectorStephen E. Butts · Chapel Hill, NCDirectorSeth M. Tjaden · Huxley, IAExecJp A. Paquin · New York, NYDirectorDax T. Mitchell · Dallas, TXExecCato Partners Management, LLC · New York, NYDirectorWilliam Burns · McKinney, TXExec · DirectorSteven M. Diedrich · Waco, TXDirectorJerry L. Whitmire · Tempe, AZDirectorvan Biema Value Partners, LLC · New York, NYDirectorJeff Siegel · Huntsville, UTExec · DirectorStephen Dalby · Lehi, UTDirectorAnupkumar M. Shetty, M.D · Dallas, TXExec · DirectorJoris M. Schuller, Jr., M.D · Dallas, TXExecHugh D. Evans · NEW YORK, NYDirectorVincent A. Levien · Florham Park, NJExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗